PRMT5 and hepatocellular carcinoma: All these data support a model whereby LINC01138 acts as a crucial effector and regulator in the oncogenic IGF2BP1/IGF2BP3-LINC01138-PRMT5 axis to maintain high steady-state levels of HCC cell proliferation and metastasis (Fig. 7f).